SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-152885
Filing Date
2012-04-06
Accepted
2012-04-06 07:05:30
Documents
7
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d329490d20f.htm 20-F 2607376
2 EX-4(A) d329490dex4a.htm EX-4.A 263403
3 EX-12.1 d329490dex121.htm EX-12.1 6457
4 EX-12.2 d329490dex122.htm EX-12.2 6438
5 EX-13.1 d329490dex131.htm EX-13.1 3385
6 EX-13.2 d329490dex132.htm EX-13.2 3366
7 EX-15.1 d329490dex151.htm EX-15.1 5936
  Complete submission text file 0001193125-12-152885.txt   2897421
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 12747080
SIC: 2835 In Vitro & In Vivo Diagnostic Substances